| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 01/05/2011 | CN101933896A Preparation used for preventing and treating animal viral diseases |
| 01/05/2011 | CN101933894A Protecting colloid for gastroenteric mucosa |
| 01/05/2011 | CN101933512A Disinfectant capable of being used with high dilution multiples, preparation method and application |
| 01/05/2011 | CN101933508A Preparation method of cyclodextrin clathrate abamectin solution |
| 01/05/2011 | CN101584682B Rutin-arabic-gum-gelatin slowreleasing microspheres and preparation thereof |
| 01/05/2011 | CN101584676B Matrine sustained release preparation and preparing method thereof |
| 01/05/2011 | CN101507819B Large-grainsize medicine intercalated hydrotalcite and preparation method thereof |
| 01/05/2011 | CN101485735B Medicament composition with stone-eliminating and expelling functions and preparation method thereof |
| 01/05/2011 | CN101185625B Rubitecan sustained-release implant for treating solid tumor |
| 01/05/2011 | CN101181234B Literdinun sustained-release implantation agent for curing entity tumour |
| 01/05/2011 | CN101066253B Slow releasing ranolazine tablet |
| 01/05/2011 | CN101020059B Medicine composition containing docetaxel matter and its preparation process |
| 01/04/2011 | US7865626 Raid storage subsystem using read connection information command to request WWN information for server table and adapter connection table |
| 01/04/2011 | US7863470 protein expression levels higher than linear polyethylenimine alone, and twice that of branched polyethylenimine, but without any significant loss in cell viability; sterols such as cholesterol conjugated via the haloformate ester reaction; drug delivery of the nucleic acids into cells |
| 01/04/2011 | US7863421 Polymer-factor VIII moiety conjugates |
| 01/04/2011 | US7863419 Antibodies having altered effector function and methods for making the same |
| 01/04/2011 | US7863415 Amino acid and peptide conjugates of amiloride and methods of use thereof |
| 01/04/2011 | US7863408 Cmprises oxyalkylene homopolymers/copolymers; for use in medical treatment |
| 01/04/2011 | US7863260 for improving microcirculation in peripheral arterial occlusive disease; maintaining normovolemia; pharmacokinetic; for therapeutic hemodilution in disturbed blood supply and arterial, especially peripheral arterial, occlusive diseases; NaCl, MgCl, KCl, CaCl2 as active ingredients |
| 01/04/2011 | US7863241 Lung surfactant polypeptide, and at least one inhibitor of a mediator of tissue destruction; for example protease inhibitors; treating inflammatory lung conditions such as asthma, chronic obstructive pulmonary disease |
| 01/04/2011 | US7863047 Intracorporeal medicaments for photodynamic treatment of disease |
| 01/04/2011 | US7862828 Allergy vaccines containing hybrid polypeptides |
| 01/04/2011 | US7862823 Multivalent vaccine composition with mixed carrier |
| 01/04/2011 | US7862817 Kit to treat ErbB2-expressing cancer in patient; humanized version of monoclonal antibody 2C4; immunoconjugate of humanized antibody conjugated with a cytotoxic agent; patient produces a greater than normal level of ErbB ligand epidermal growth factor, transforming growth factor alpha |
| 01/04/2011 | US7862807 Biologically active molecule bonded to a dendrimer having a guanidine, protonated guanidine, protected guanidine, amidine, protonated amidine group, ureido, at protonated ureido group, protected ureido, a thioureido group, and a protonated thioureido goup; increasing the bioavailability of a drug |
| 01/04/2011 | US7862798 Vitamin-targeted imaging agents |
| 01/04/2011 | CA2573307C Use of platelet aggregation inhibitors |
| 01/04/2011 | CA2558191C Composition containing benzamidine derivative and method for stabilizing benzamidine derivative |
| 01/04/2011 | CA2543722C Tocopherol-modified therapeutic drug compounds |
| 01/04/2011 | CA2532631C Nasal pharmaceutical composition of piribedil |
| 01/04/2011 | CA2500190C Linker compound, ligand, and producing method thereof |
| 01/04/2011 | CA2481754C Antibiotic/benzoyl peroxide dispenser |
| 01/04/2011 | CA2479638C Hfa-suspension formulations of crystalline tiotropium bromide anhydrate |
| 01/04/2011 | CA2474343C Nsaid-containing topical formulations that demonstrate chemopreventive activity |
| 01/04/2011 | CA2463259C Chewable tablet containing lysine |
| 01/04/2011 | CA2460920C Stent coated with a sustained-release drug delivery and method for use thereof |
| 01/04/2011 | CA2449054C Integrin targeting liposome for nucleic acid delivery |
| 01/04/2011 | CA2447335C Targeted delivery of drugs for the treatment of viral infections |
| 01/04/2011 | CA2444569C A novel coating for a sustained release pharmaceutical composition |
| 01/04/2011 | CA2443728C Pharmaceutical composition based on macrolides for topical application in ophthalmology |
| 01/04/2011 | CA2429486C O/w emulsion composition and method of preparing the same |
| 01/04/2011 | CA2419423C Conjugates of peptides and peptide mimetics having integrin inhibitor properties |
| 01/04/2011 | CA2384670C Nanoparticulate compositions comprising amorphous cyclosporine and methods of making and using such compositions |
| 01/04/2011 | CA2379909C Drug releasing biodegradable fiber implant |
| 01/04/2011 | CA2333317C Stable oil-in-glycerin emulsion |
| 01/04/2011 | CA2319672C Compounds and compositions for delivering active agents |
| 01/04/2011 | CA2317505C Enzyme catalyzed therapeutic agents |
| 01/04/2011 | CA2307000C Veterinary vaccines |
| 01/04/2011 | CA2303338C Water soluble paclitaxel derivatives |
| 01/04/2011 | CA2285018C Multiple antigen glycopeptide carbohydrate, vaccine comprising the same and use thereof |
| 01/04/2011 | CA2246747C Method of promoting bone growth with hyaluronic acid and growth factors |
| 01/04/2011 | CA2231916C Erythrocytes loaded with s-nitrosothiol and uses therefor |
| 01/04/2011 | CA2217191C Pharmaceutical composition containing pectin and a phospholipid, used as an antidiarrheal and antiulcer agent |
| 01/04/2011 | CA2129899C Dual carrier immunogenic construct |
| 12/30/2010 | US20100331968 Zeolites for Delivery of Nitric Oxide |
| 12/30/2010 | US20100331529 Methods for increasing protein polyethylene glycol (peg) conjugation |
| 12/30/2010 | US20100331489 Branched water-soluble polymers and their conjugates |
| 12/30/2010 | US20100331445 Systems For Self-Healing Composite Materials |
| 12/30/2010 | US20100331430 Pharmaceutical compositions containing propionic preservative components |
| 12/30/2010 | US20100331428 Sonic Low Pressure Spray Drying |
| 12/30/2010 | US20100331423 Aqueous solution of olanexidine, method of preparing the aqueous solution, and disinfectant |
| 12/30/2010 | US20100331422 Stable hydroalcoholic compositions |
| 12/30/2010 | US20100331421 Disinfectant and/or bactericidal aqueous compositions |
| 12/30/2010 | US20100331407 Clear ophthalmic solution comprising latanoprost as active ingredient |
| 12/30/2010 | US20100331395 Decoy-containing pharmaceutical compositions and method of using the same |
| 12/30/2010 | US20100331382 Processes of making and using pharmaceutical formulations of antineoplastic agents |
| 12/30/2010 | US20100331356 Self-microemulsifying drug delivery systems |
| 12/30/2010 | US20100331273 Self-assembling complex for targeting chemical agents to cells |
| 12/30/2010 | US20100331232 Starch-based hydrogel for biomedical applications |
| 12/30/2010 | US20100331202 Nanotube structures having a surfactant bilayer inner wall coating |
| 12/30/2010 | US20100331191 Surfactant compounds |
| 12/30/2010 | US20100331187 Formulations |
| 12/30/2010 | US20100331177 Amorphous silica particles having high absorbing capabilities and high structural characteristics |
| 12/30/2010 | US20100330189 Sustained release beads and suspensions including the same for sustained delivery of active ingredients |
| 12/30/2010 | US20100330184 Injection vehicle for polymer-based formulations |
| 12/30/2010 | US20100330165 Use of chemotherapeutic agents |
| 12/30/2010 | US20100330164 Method of increasing tear production with purinergic receptor agonists |
| 12/30/2010 | US20100330159 System for transporting active substances in a biological system |
| 12/30/2010 | US20100330157 Biomaterial for the controlled delivery of ingredients |
| 12/30/2010 | US20100330072 Myostatin binding agents |
| 12/30/2010 | US20100330058 Chewable drug |
| 12/30/2010 | US20100330054 Preparation, use of preparation for treatment, and method of treatment of intestinal infection |
| 12/30/2010 | US20100330011 Silicone-Organic Gels with Polyalkyloxylene Crosslinked Silicone Elastomers |
| 12/30/2010 | US20100329992 Shiga toxin b-subunit as a vector for tumor diagnosis and drug delivery to gb3 expressing tumors |
| 12/30/2010 | US20100329984 Respiratory dispersion for metered dose inhalers |
| 12/30/2010 | US20100329982 Particles with inducible change of shape |
| 12/30/2010 | US20100329976 Nanoparticulate compositions of angiogenesis inhibitors |
| 12/30/2010 | US20100327013 Foamable alcohol compositions, systems and methods of use |
| 12/29/2010 | WO2010151653A2 Terpene glycosides and their combinations as solubilizing agents |
| 12/29/2010 | WO2010151353A2 Injectable beta-hairpin peptide hydrogel that kills methicillin-resistant staphylococcus aureus |
| 12/29/2010 | WO2010151173A1 Nano-dispersed composition containing coenzyme q10 and method for producing same |
| 12/29/2010 | WO2010151073A2 Conjugates of anticancer chemotherapeutic agent-chlorine derivatives, photosensitizer containing same and composition for treating cancer containing same |
| 12/29/2010 | WO2010151020A2 Fast-dissolving oral film for effectively concealing unpleasant tastes |
| 12/29/2010 | WO2010150930A1 Fast dissolving film for oral administration which prevents unpleasant taste effectively |
| 12/29/2010 | WO2010150812A1 Ophthalmic composition and method for prevention of cloudiness/precipitation |
| 12/29/2010 | WO2010150708A1 Protein-modifying agent |
| 12/29/2010 | WO2010150400A1 Jelly preparation containing isosorbide |
| 12/29/2010 | WO2010150378A1 Ophthalmic composition |
| 12/29/2010 | WO2010150255A1 Conjugates of cytotoxic drugs |
| 12/29/2010 | WO2010150036A1 Sol-gel nanostructured and biocompatible platinum-titania and platinum- silica biocatalysts nanostructured and biocompatible for use in cancer treatment |